+Susen Rogen

Friday, 27 September 2013

Israel Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports
 
Complimentary Downloads

7 Days of Complimentary Downloads: 100,000+ Motion Backgrounds, Video Clips, Production Music Tracks, Sound Effects, Special Effects and More.
From our sponsors
Israel Pharmaceuticals and Healthcare Report Q4 2013
Sep 25th 2013, 00:00, by swapnil

BMI View: Israel’s pharmaceutical market is a very attractive prospect for multinationals looking to launch innovative medicines. Favourable factors include high per capita spending on medicines, a market size approaching US$2bn, a high proportion of pensioners and a largely urbanised population. However, we caution that poor patent respect and a lack of business transparency remain key threats to company revenues. Additionally, we hold a relatively less optimistic outlook for growth in the market, based on weaker private consumption over the medium term. Headline Expenditure Projections ? Pharmaceuticals: ILS7.13bn (US$1.85bn) in 2012 to ILS7.39bn (US$2.05bn) in 2013; +3.7% in local currency …

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=117445.

Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/israel-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment